Thermo Fisher Scientific Debuts Orbitrap Exploris EFOX Mass Detector - Food Engineering Mag
#Fisher Scientific#Scientific Debuts#Debuts Orbitrap#Orbitrap Exploris#Exploris EFOX
Life Science News
Latest updates from the biotech and pharma world
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
#Billion Buyback#Fisher Unveils#Dividend Intact#Yahoo Finance#Thermo Fisher
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
#Genomics Tops#Cuts Losses#Losses Finimize#Genomics#Tops
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
#Strong Sales#Stock Jumps#Markets Financial#Financial Content#NASDAQ
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
#Genomics Reports#Financial Results#Results Barchart.com#Genomics#Quarter
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
#Genomics Reports#Financial Results#Eastern Progress#Results Eastern#Genomics
Targeted Protein Degradation: How Chemoproteomics and Induced Proximity Are Shaping Drug Discovery
#Induced Proximity#Protein Degradation#Drug Discovery#Proximity Symposium#TPD
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
#Stock Jumped#Thermo Fisher#Fisher Scientific#Scientific Stock#Jumped
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - Business Wire
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
#Beats Revenue#Revenue Estimates#Estimates Nasdaq#Genomics#TXG
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
#Genomics earnings#revenue topped#earnings beat#estimates Investing.com#topped estimates
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
#Key Metrics#Metrics Nasdaq#Genomics#TXG#Earnings
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
#Stock Titan#guides fourth‑quarter#fourth‑quarter revenue#Genomics#NASDAQ
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
#Key Metrics#Yahoo Finance#Metrics Yahoo#Genomics#TXG
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
#Beats Revenue#Yahoo Finance#Revenue Estimates#Estimates Yahoo#Genomics
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
#Strong Sales#Stock Jumps#Yahoo Finance#NASDAQ#TXG
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire
#Genomics Reports#Financial Results#Genomics#Quarter#Financial
Solving formulation challenges with Lonza’s advanced technologies - Nutraceutical Business Review
#Nutraceutical Business#Business Review#Solving formulation#formulation challenges#Review Solving
Cytiva Launches Fibro dT Platform - Contract Pharma
#Launches Fibro#Contract Pharma#Cytiva Launches#Platform Contract#Pharma Cytiva
China to lift 8-month ban on imports of Illumina’s gene sequencers - Times of San Diego
#San Diego#Diego China#gene sequencers#sequencers Times#Illumina